ECVT Stock Analysis: Buy, Sell, or Hold?

ECVT - Ecovyst Inc.

CHEMICALS & ALLIED PRODUCTS
$13.16
0.32 (2.49%) β–²
5d: +9.85%
30d: +16.77%
90d: +32.13%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation

ECVT is down 3.1% this week, but smart money is accumulating calls. Top strike: $7.5 2026-04-17 with 4 OI. Call ratio: 100% View Scanner →

Strength: 6.6/10

Get Alerted When ECVT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ“Š HOLD: ECVT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$24.79
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.39
14.5% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ECVT is currently trading at $13.16, which is considered extended relative to its 30-day fair value range of $11.15 to $12.35. The stock's valuation (Forward PE: 16.7) is in line with its historical norms (16.6). At these levels, the market is pricing in 0.2% annual earnings growth.

Technical Outlook: Technically, ECVT is in a strong uptrend. The price is approaching resistance at $13.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: ECVT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.20 (+10.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $11.15 - $12.35
Company Quality Score 64/100 (BUY)
Volume Confirmation HIGH
Confidence Score 58.1%

All Signals

  • BEARISH: Price extended above range (+6.6% above fair value)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($14.20)
  • BULLISH: Expecting earnings turnaround to 0.2% growth with 34.0% revenue growth

Fair Price Analysis

30-Day Fair Range $11.15 - $12.35
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $11.40
Resistance Level $13.27
Current Trend Strong Uptrend
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 16.74
Wall Street Target $14.20 (+10.6%)
Revenue Growth (YoY) 34.0%
Earnings Growth (YoY) -28.6%
Profit Margin -9.8%
Valuation Premium vs History +0.2% premium
PE vs Historical 16.7 vs 16.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +0.2% (market-implied from PE analysis)
1-Year Target $12.87 (+0%)
2-Year Target $12.89 (+0%)
3-Year Target $12.92 (+1%)
3-Yr Target (if PE normalizes) (PE: 17β†’17) PE COMPRESSION $12.81 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.4, Growth: 27.4%) $35.53 (+177%)
Base: (SPY PE: 16.7, Growth: 27.4%) $26.56 (+107%)
Bear: (PE: 14.2, Growth: 27.4%) $22.57 (+76%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Forward PE: 20.75 | Forward EPS (Implied): $0.58
Bull Case $14.47 (+21%)
Analyst growth 15.0%, PE expands to 21.8
Base Case $11.98 (0%)
Market implied 0.0%, PE stable at 20.8
Bear Case $9.16 (-24%)
Severe decline -15.0%, PE contracts to 18.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 11:47 AM ET
Data refreshes hourly during market hours. Next update: 12:47 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ECVT.

Create Free Account

Already have an account? Log In

Top Rated Specialty Chemicals Stocks

Top-rated stocks in Specialty Chemicals by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LIN
Linde plc Ordinary Shares
BUY
28 analysts
$516 60 HOLD
SHW
Sherwin-Williams Co
BUY
28 analysts
$388 62 BUY
IFF
International Flavors & …
STRONG BUY
22 analysts
$91 63 BUY
APD
Air Products and Chemica…
BUY
24 analysts
$308 63 BUY
DD
Dupont De Nemours Inc
STRONG BUY
20 analysts
$53 60 BUY

More Analysis for ECVT

ECVT Technical Chart ECVT Price Prediction ECVT Earnings Date ECVT Investment Advisor ECVT Fair Price Analyzer ECVT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals